# Anaptysbio, Inc: Form DEF 14A, filed Apr 24, 2024

- Company: [Anaptysbio, Inc](/companies/anab.md) (CIK 1370053)
- Form: DEF 14A
- Filed: 2024-04-24
- Accepted by EDGAR: Apr 24, 2024, 16:05 ET
- Period: 2024-06-12
- Accession: 0001370053-24-000019
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1370053/000137005324000019/proxystatementfy2023_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1370053/000137005324000019/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1370053/000137005324000019/proxystatementfy2023_def14a.htm

Filed Apr 24, 2024.
Source: SEC EDGAR, the filing index for accession 0001370053-24-000019. Last ingested by Listed: Nov 13, 2026, 16:10 ET. No prices; not investment advice.
